Gender disparity in HCC: Is it the fat and not the sex?

por Greten, Tim F.
Publicado 2019

Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma

por Yu, Su Jong, Greten, Tim F.
Publicado 2020

Locally Advanced Cancer of the Esophagus, Current Treatment Strategies, and Future Directions

por Rahma, Osama E., Greten, Tim F., Duffy, Austin
Publicado 2012

Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapy

por Brar, Gagandeep, Greten, Tim F., Brown, Zachary J.
Publicado 2018

Establishment of Orthotopic Liver Tumors by Surgical Intrahepatic Tumor Injection in Mice with Underlying Non-Alcoholic Fatty Liver Disease

por Brown, Zachary J., Heinrich, Bernd, Greten, Tim F.
Publicado 2018

Human Th17 cells in patients with cancer: Friends or foe?

por Greten, Tim F., Zhao, Fei, Gamrekelashvili, Jaba, Korangy, Firouzeh
Publicado 2012

Molecular therapy for the treatment of hepatocellular carcinoma

por Greten, T F, Korangy, F, Manns, M P, Malek, N P
Publicado 2009

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

por Monge, Cecilia, Xie, Changqing, Steinberg, Seth M, Greten, Tim F
Publicado 2021

Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production in vivo and in vitro

por Wabitsch, Simon, McCallen, Justin D., Ma, Chi, Greten, Tim F.
Publicado 2021

Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States

por Monge, Cecilia, Maldonado, J Alberto, McGlynn, Katherine A, Greten, Tim F
Publicado 2023

Agonistic CD40 antibody induces immune-mediated liver damage and modulates tumor-induced myeloid suppressive cells

por Medina-Echeverz, Jose, Ma, Chi, Duffy, Austin, Kleiner, David E, Greten, Tim F
Publicado 2014

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells

por Lankiewicz, Silke, Rother, Eva, Zimmermann, Silke, Hollmann, Christiane, Korangy, Firouzeh, Greten, Tim F.
Publicado 2008

Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer

por Brown, Zachary J., Heinrich, Bernd, Steinberg, Seth M., Yu, Su Jong, Greten, Tim F.
Publicado 2017

Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage

por Eggert, Tobias, Medina-Echeverz, José, Kapanadze, Tamar, Kruhlak, Michael J., Korangy, Firouzeh, Greten, Tim F.
Publicado 2014

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients

por Greten, T F, Papendorf, F, Bleck, J S, Kirchhoff, T, Wohlberedt, T, Kubicka, S, Klempnauer, J, Galanski, M, Manns, M P
Publicado 2005

Immune studies in a mouse model of MET and CAT induced liver tumors

por Eggert, Tobias, Medina-Echeverz, Jose, Ma, Chi, Stauffer, Jimmy K, Wiltrout, Robert H, Greten, Tim F
Publicado 2014

Primary sterile necrotic cells fail to cross-prime CD8(+) T cells

por Gamrekelashvili, Jaba, Ormandy, Lars A., Heimesaat, Markus M., Kirschning, Carsten J., Manns, Michael P., Korangy, Firouzeh, Greten, Tim F.
Publicado 2012

miR-130a and miR-145 reprogram Gr-1(+)CD11b(+) myeloid cells and inhibit tumor metastasis through improved host immunity

por Ishii, Hiroki, Vodnala, Suman K., Achyut, Bhagelu R., So, Jae Young, Hollander, M. Christine, Greten, Tim F., Lal, Ashish, Yang, Li
Publicado 2018

Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis

por Brar, Gagandeep, Greten, Tim F., Graubard, Barry I., McNeel, Timothy S., Petrick, Jessica L., McGlynn, Katherine A., Altekruse, Sean F.
Publicado 2020

Loss of myeloid‐specific lamin A/C drives lung metastasis through Gfi‐1 and C/EBPε‐mediated granulocytic differentiation

por Ishii, Hiroki, Park, Woo‐Yong, So, Jaeyoung, Kuhn, Skyler, Koparde, Vishal N., Pang, Yanli, Greten, Tim F., Hollander, M. Christine, Yang, Li
Publicado 2020